Product Information
ASMANEX TWISTHALER 110 MCG #30 is a brand product labeled by Organon LLC, priced at $88.8306 per EA under NDC 78206011501. Its NADAC has been published 261 times since Oct 6, 2021.
FDA first approved this application on Mar 30, 2005.
The High Outlier badge above means this manufacturer's average price in the Mometasone Furoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
110 ug/1
Manufacturer
Organon LLCNDC
78206011501
Classification
Brand
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA021067FDA Approved
3/30/2005
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ASMANEX TWISTHALER 110 MCG #30 has been published 261 times since Oct 6, 2021, and over the history we have for it it has declined 47.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $88.8306 per EA |
|---|---|
| All-time high | $178.6480 (Jan 3, 2024) |
| All-time low | $88.8306 (Sep 23, 2026) |
| 52-week high | $89.0452 |
| 52-week low | $88.8306 |
| Median price | $89.4011 |
| Average price | $129.1277 |
| Largest weekly change | -50.0% (Jan 10, 2024) |
| Weeks tracked | 261 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Mometasone Furoate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mometasone Furoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASMANEX TWISTHALER 110 MCG #30?
The current National Average Drug Acquisition Cost (NADAC) for ASMANEX TWISTHALER 110 MCG #30, manufactured by Organon LLC, is $88.8306 per EA (NDC 78206011501), effective Sep 30, 2026.
How has the price of ASMANEX TWISTHALER 110 MCG #30 changed over time?
Over the history we have for it, the NADAC for ASMANEX TWISTHALER 110 MCG #30 has declined 47.8%. It has been tracked across 261 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for ASMANEX TWISTHALER 110 MCG #30?
Since Oct 6, 2021, the NADAC for ASMANEX TWISTHALER 110 MCG #30 has ranged from a low of $88.8306 (Sep 23, 2026) to a high of $178.6480 (Jan 3, 2024), with a median of $89.4011 per EA.
Are there cheaper alternatives to ASMANEX TWISTHALER 110 MCG #30?
No other NADAC-published product currently shares the active ingredient and strength of ASMANEX TWISTHALER 110 MCG #30 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASMANEX TWISTHALER 110 MCG #30?
ASMANEX TWISTHALER 110 MCG #30 (NDC 78206011501) is labeled by Organon LLC, and CMS classifies it as a brand product.